nach oben

Current Sexual Health Reports

Erschienen in:

12.07.2018 | Medical Comorbidities (A Goldstein, M Miner, and S Parish, Section Editors)

Interstitial Cystitis and Sexual Dysfunction: Diagnostic Accuracy Is Essential

verfasst von: Rachel S. Rubin, Elizabeth Malphrus

Erschienen in: Current Sexual Health Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review the current literature regarding sexual dysfunction and interstitial cystitis/bladder pain syndrome (IC/BPS). Our goal was to review the epidemiology and overlap of these two conditions as well discuss the success of various IC/BPS treatment modalities with improving sexual function.

Recent Findings

Women with IC/BPS have a much higher incidence of sexual dysfunction as compared to controls, and this is often a significant predictor of poor quality of life. IC/BPS is thought to have various phenotypes and is associated with a number of overlapping chronic conditions which may contribute to sexual dysfunction thus making an accurate diagnosis imperative. Various treatments for IC/BPS may improve certain domains of sexual function.

Summary

It is not surprising that IC/BPS, a chronic pelvic pain condition, negatively affects sexual function. More research is needed not just on the prevalence of sexual dysfunction in this patient population, but specifically on treatment options and ways to improve sexual function in these distressed patients.

Douglas-Moore JL, Goddard J. Current best practice in the management of cystitis and pelvic pain. Ther Adv Urol. 2018;10:17–22. https://doi.org/10.1177/1756287217734167.CrossRefPubMed

Malik ST, Birch BR, Voegeli D, Fader M, Foria V, Cooper AJ, et al. Distribution of mast cell subtypes in interstitial cystitis: implications for novel diagnostic and therapeutic strategies? J Clin Pathol. 2018; Available from: http://jcp.bmj.com/content/early/2018/05/15/jclinpath-2017-204881.abstract

Bassi PF, Costantini E, Foley S, Palea S. Glycosaminoglycan therapy for bladder diseases: emerging new treatments. Eur Urol Suppl. 2011;10:451–011.CrossRef

Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology. 2007;69:34–007.CrossRefPubMed

Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH. Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis. Urology. 2011;77:576–80. https://doi.org/10.1016/j.urology.2010.10.016.CrossRefPubMedPubMedCentral

Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol. 2007;177:450–6. https://doi.org/10.1016/j.juro.2006.09.032.CrossRefPubMed

Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol. 2009;182:155–60. https://doi.org/10.1016/j.juro.2009.02.122.CrossRefPubMed

•• Liu B, Su M, Zhan H, Yang F, Li W, Zhou X. Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. Urology. 2014;84:1308–13. https://doi.org/10.1016/j.urology.2014.08.018. Highlights that sexual dysfunction is an important predictor to IC/BPS symptom severity and should be added as a phenotype of the disorder.CrossRefPubMed

Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, et al. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women: f asome have proposed incorporating measures l review. Menopause N Y N. 2018;25:837–47.CrossRef

10.

Womenowenstein L, et al. The role of androgens in the treternet]. Northwestern University; [cited 2017 Nov 17]. Available from: http://menopause.northwestern. edu/content/genitourinary-syndrome-menopause.

11.

•• Gardella B, Porru D, Nappi RE, Daccò MD, Chiesa A, Spinillo A. Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study. J Sex Med. 2011;8:1726–34. https://doi.org/10.1111/j.1743-6109.2011.02251.x. All the patients with sexual dysfunction and IC/BPS also had vulvodynia. Important to find and treat all underlying causes of pelvic pain.CrossRefPubMed

12.

Abernethy MG, Rosenfeld A, White JR, Mueller MG, Lewicky-Gaupp C, Kenton K. Urinary Microbiome and Cytokine levels in women with interstitial cystitis. Obstet Gynecol. 2017;129:500–6. https://doi.org/10.1097/AOG.0000000000001892. CrossRefPubMed

13.

Chiu C-D, Lee M-H, Chen W-C, Ho HL, Wu H-C. Childhood trauma perpetrated by close others, psychiatric dysfunction, and urological symptoms in patients with interstitial cystitis/bladder pain syndrome. J Psychosom Res. 2017;93:90–5. https://doi.org/10.1016/j.jpsychores.2016.12.014.CrossRefPubMed

14.

Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK, et al. Childhood sexual trauma in women with interstitial cystitis/bladder pain syndrome: a case control study. Can Urol Assoc J J Assoc Urol Can. 2011;5:410–5. https://doi.org/10.5489/cuaj.11110.CrossRef

15.

Seth A, Teichman JMH. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history. J Urol. 2008;180:2029–33. https://doi.org/10.1016/j.juro.2008.07.053.CrossRefPubMed

16.

Tripp DA, Nickel JC, Fitzgerald MP, Mayer R, Stechyson N, Hsieh A. Sexual functioning, catastrophizing, depression, and pain, as predictors of quality of life in women with interstitial cystitis/painful bladder syndrome. Urology. 2009;73:987–92. https://doi.org/10.1016/j.urology.2008.11.049.CrossRefPubMed

17.

Troxel WM, Booth M, Buysse DJ, Elliott MN, Suskind AM, Clemens JQ, et al. Sleep disturbances and nocturnal symptoms: relationships with quality of life in a population-based sample of women with interstitial cystitis/bladder pain syndrome. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2014;10:1331–7. https://doi.org/10.5664/jcsm.4292. CrossRef

18.

Meng E, Hsu Y-C, Chuang Y-C. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). Low Urin Tract Symptoms. 2018;10:3–11. https://doi.org/10.1111/luts.12214.CrossRefPubMed

19.

Nickel JC, Parsons CL, Forrest J, Kaufman D, Evans R, Chen A, et al. Improvement in sexual functioning in patients with interstitial cystitis/painful bladder syndrome. J Sex Med. 2008;5:394–9. https://doi.org/10.1111/j.1743-6109.2007.00686.x.CrossRefPubMed

20.

Hung M-J, Su T-H, Lin Y-H, Huang W-C, Lin T-Y, Hsu C-S, et al. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution. J Sex Med. 2014;11:2256–63. https://doi.org/10.1111/jsm.12507.CrossRefPubMed

21.

Hsieh C-H, Chang S-T, Hsieh C-J, Hsu C-S, Kuo T-C, Chang H-C, et al. Treatment of interstitial cystitis with hydrodistention and bladder training. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1379–84. https://doi.org/10.1007/s00192-008-0640-9. CrossRefPubMed

22.

Fariello JY, Whitmore K. Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction. Int Urogynecol J. 2010;21:1553–8. https://doi.org/10.1007/s00192-010-1281-3.CrossRefPubMed

23.

Wehbe SA, Whitmore K, Ho MH. Sacral neuromodulations for female lower urinary tract, pelvic floor, and bowel disorders. Curr Opin Obstet Gynecol. 2010;22:414–9. https://doi.org/10.1097/GCO.0b013e32833e49d7.CrossRefPubMed

24.

Pauls RN, Marinkovic SP, Silva WA, Rooney CM, Kleeman SD, Karram MM. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:391–5. https://doi.org/10.1007/s00192-006-0168-9. CrossRefPubMed

25.

Schmid C, Berger K, Müller M, Silke J, Mueller MD, Kuhn A. Painful bladder syndrome: management and effect on sexual function and quality of life. Ginekol Pol. 2011;82:96–101.PubMed

26.

Hanno PM, Erickson D, Moldwin R, Faraday MM. American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545–53. https://doi.org/10.1016/j.juro.2015.01.086. CrossRefPubMed

27.

FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187:2113–8. https://doi.org/10.1016/j.juro.2012.01.123.CrossRefPubMedPubMedCentral

28.

Kottmel A, Goldstein I. Vulvoscopy. J Sex Med. 2012;9:2990–3. https://doi.org/10.1111/jsm.12017.CrossRef

29.

Gagnon C, Minton J, Goldstein I. Vestibular anesthesia test for neuroproliferative vestibulodynia. J Sex Med. 2014;11:1888–91. https://doi.org/10.1111/jsm.12630.CrossRefPubMed

30.

Sarton J. Assessment of the pelvic floor muscles in women with sexual pain. J Sex Med. 2010;7:3526–9. https://doi.org/10.1111/j.1743-6109.2010.02059.x.CrossRefPubMed

Titel: Interstitial Cystitis and Sexual Dysfunction: Diagnostic Accuracy Is Essential
verfasst von: Rachel S. Rubin
Elizabeth Malphrus
Publikationsdatum: 12.07.2018
Verlag: Springer US
Erschienen in: Current Sexual Health Reports / Ausgabe 3/2018
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI: https://doi.org/10.1007/s11930-018-0162-5

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Couple Sex Therapy Versus Group Therapy for Women with Genito-pelvic Pain

Understanding Sexual Partner Preference: from Biological Diversity to Psychiatric Disorders

Opioid-Related Sexual Dysfunction in Men

Testosterone Therapy: a Panacea for Sexual Dysfunction in Men?